• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 18.14
  • VXN 24.38
  • VXO 19.94
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





YES
Refresh      
PRGO (Perrigo Company plc)
Last Trade 63.27 Dividend/Share 0.76 PE Ratio 13.05
Date November 16-2018 Dividend Yield 1.201 Return on Assets 1.08
Change -0.24 ExDividend Date 2018-11-29 Return on Capital null
Bid null Latest EPS 0.84 Price/Sale 1.790
Ask null LatestEPS Date 2017-12-31 Price to Book 1.52
Volume null EPS ttm 4.8500000000000005 Institutional % 112.3
Avg Volume 1.74M Shares Outstanding 135.86M Insider % 0.6
Open 63.27 Float 135.02M Short Ratio 5.390
Prev Close 63.51 Return On Equity 2.1 5 Year Change % -0.573
High 63.87 Consensus EPS 1.05 2 Year Change % -0.272
Low 62.82 No. of Estimate 12.000 1 Year Change % -0.257
52 Week High 95.93 EPS Surprise $ null YTD Change % -0.289
52 Week Low 62.48 EPS Surprise Percent 3.8095 6 Month Change % -0.162
52 Week Change -26.603 EBITDA 0M 3 Month Change % -0.131
50 Day MA 70.9864 Revenue 0M 1 Month Change % -0.143
200 Day MA Gross Profit 0M 5 Day Change % -0.035
Market Cap 8595.64M Cash 0M 30 Day Change % -0.131
Beta 0.61135 Debt 0M Stock Exchange New York Stock Exchange
Sector Healthcare Revenue Per Share 0 Short Interest 7933951
Short Date 2018-10-31 Revenue Per Employee 0 Short Ratio 5.390
Company Profile

Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and medical diagnostic products worldwide. The company operates through three segments: Consumer Healthcare, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical and nutritional products, which include analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, and vitamin and nutritional supplement products. The Rx Pharmaceuticals segment develops, manufactures, and markets generic prescription drug products, including creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquid suspensions, and solutions, as well as nasal sprays, oral liquids, and transdermal products. The API segment engages in the development, manufacture, and marketing of APIs used by the generic drug industry and branded pharmaceutical companies. Perrigo Company also manufactures and markets branded prescription drugs; and imports pharmaceutical, diagnostics, and other medical products. The company has collaborative agreements with Medicis Pharmaceutical Corporation, Medimetriks Pharmaceuticals, Cobrek Pharmaceuticals, and Cephalon Inc. Its customers primarily include retail drug companies, supermarkets, wholesalers, chain drug stores, hospitals and hospital systems, mass merchandise chains, and group purchasing organizations. The company was founded in 1887 and is headquartered in Allegan, Michigan.